Title: Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome.
Journal: Human molecular genetics 20120915
Title: Roles of glycogen synthase kinase 3 in Alzheimer's disease.
Journal: Current Alzheimer research 20120901
Title: Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20120523
Title: Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
Journal: Diabetes 20030301
Title: Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Journal: Diabetes 20000201
Title: Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Journal: Diabetes 19990801
Title: Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America 19930815
Title: Ring DB, et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003 Mar;52(3):588-95.
Title: Naujok O, et al. Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors. BMC Res Notes. 2014 Apr 29;7:273.
Title: Zajkowski T, et al. Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein. Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2228-39.
